[Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer]. 1986

K Nishida, and T Yamamoto, and K Yoshioka, and M Iida, and H Miyagawa, and T Yoshikawa, and S Sugino, and M Kondo

The levels of the serum carbohydrate antigen (CA) 19-9 were assayed in 284 cases including 77 patients with gastric cancer. The CA 19-9 levels were positive in 38% of gastric cancer cases, and they were significantly higher than those of benign gastric diseases. Extremely increased levels were found in advanced gastric cancer, but not in early gastric cancer. There was no significant correlation between CA 19-9 and CEA, and CA 19-9 seemed to be superior to CEA in specificity for gastric cancer, but inferior in sensitivity. Thus, the assay of CA 19-9 in combination with CEA could be helpful in the differentiation between benign and malignant gastric diseases.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D001661 Biliary Tract Neoplasms Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER. Biliary Tract Cancer,Cancer of Biliary Tract,Cancer of the Biliary Tract,Neoplasms, Biliary Tract,Biliary Tract Cancers,Biliary Tract Neoplasm,Cancer, Biliary Tract,Cancers, Biliary Tract,Neoplasm, Biliary Tract
D013160 Splenic Neoplasms Tumors or cancer of the SPLEEN. Cancer of Spleen,Spleen Cancer,Cancer of the Spleen,Neoplasms, Splenic,Spleen Neoplasms,Splenic Cancer,Cancer, Spleen,Cancer, Splenic,Cancers, Spleen,Cancers, Splenic,Neoplasm, Spleen,Neoplasm, Splenic,Neoplasms, Spleen,Spleen Cancers,Spleen Neoplasm,Splenic Cancers,Splenic Neoplasm
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D015295 Antigens, Tumor-Associated, Carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. Antigens, Carbohydrate, Tumor-Associated,CA Antigens,Cancer-Associated Carbohydrate Antigens,Carbohydrate Antigens, Tumor-Associated,Tumor-Associated Carbohydrate Antigens,Antigen, Carcinoma-Associated,CA Antigen,CA(Oxford) Antigen,Carcinoma-Associated Antigen,Epitectin,Antigen, CA,Antigen, Carcinoma Associated,Antigens, CA,Antigens, Cancer-Associated Carbohydrate,Antigens, Tumor-Associated Carbohydrate,Cancer Associated Carbohydrate Antigens,Carbohydrate Antigens, Cancer-Associated,Carbohydrate Antigens, Tumor Associated,Carcinoma Associated Antigen,Tumor Associated Carbohydrate Antigens

Related Publications

K Nishida, and T Yamamoto, and K Yoshioka, and M Iida, and H Miyagawa, and T Yoshikawa, and S Sugino, and M Kondo
December 1984, Igaku kenkyu. Acta medica,
K Nishida, and T Yamamoto, and K Yoshioka, and M Iida, and H Miyagawa, and T Yoshikawa, and S Sugino, and M Kondo
February 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
K Nishida, and T Yamamoto, and K Yoshioka, and M Iida, and H Miyagawa, and T Yoshikawa, and S Sugino, and M Kondo
February 2017, Surgery today,
K Nishida, and T Yamamoto, and K Yoshioka, and M Iida, and H Miyagawa, and T Yoshikawa, and S Sugino, and M Kondo
November 2021, Annals of surgical treatment and research,
K Nishida, and T Yamamoto, and K Yoshioka, and M Iida, and H Miyagawa, and T Yoshikawa, and S Sugino, and M Kondo
November 1996, Annals of clinical biochemistry,
K Nishida, and T Yamamoto, and K Yoshioka, and M Iida, and H Miyagawa, and T Yoshikawa, and S Sugino, and M Kondo
March 1991, Changgeng yi xue za zhi,
K Nishida, and T Yamamoto, and K Yoshioka, and M Iida, and H Miyagawa, and T Yoshikawa, and S Sugino, and M Kondo
January 2006, Clinical chemistry and laboratory medicine,
K Nishida, and T Yamamoto, and K Yoshioka, and M Iida, and H Miyagawa, and T Yoshikawa, and S Sugino, and M Kondo
September 2013, The Journal of clinical endocrinology and metabolism,
K Nishida, and T Yamamoto, and K Yoshioka, and M Iida, and H Miyagawa, and T Yoshikawa, and S Sugino, and M Kondo
March 1986, Gastroenterologie clinique et biologique,
K Nishida, and T Yamamoto, and K Yoshioka, and M Iida, and H Miyagawa, and T Yoshikawa, and S Sugino, and M Kondo
June 2001, Clinical chemistry and laboratory medicine,
Copied contents to your clipboard!